CNGA2
Basic information
Region (hg38): X:151734746-151745564
Previous symbols: [ "CNCA1", "CNCA" ]
Links
Phenotypes
GenCC
Source:
- isolated congenital anosmia (Supportive), mode of inheritance: AD
- anosmia (Limited), mode of inheritance: XL
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CNGA2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 46 | 55 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 46 | 8 | 9 |
Variants in CNGA2
This is a list of pathogenic ClinVar variants found in the CNGA2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-151738497-C-A | not specified | Uncertain significance (Jun 10, 2024) | ||
X-151738527-A-C | Benign (Apr 23, 2018) | |||
X-151738556-A-G | not specified | Uncertain significance (May 02, 2024) | ||
X-151738589-A-G | not specified | Conflicting classifications of pathogenicity (Sep 13, 2023) | ||
X-151738784-C-T | Benign (Dec 31, 2019) | |||
X-151738800-G-C | not specified | Uncertain significance (Mar 31, 2024) | ||
X-151738805-C-T | Likely benign (Mar 01, 2023) | |||
X-151739588-G-C | not specified | Uncertain significance (Jan 16, 2024) | ||
X-151739612-G-A | not specified | Uncertain significance (Apr 09, 2024) | ||
X-151739641-C-G | not specified | Uncertain significance (Dec 05, 2022) | ||
X-151739660-C-T | not specified | Uncertain significance (Aug 28, 2024) | ||
X-151739681-C-A | not specified | Uncertain significance (Feb 10, 2022) | ||
X-151739689-G-C | not specified | Uncertain significance (Apr 18, 2023) | ||
X-151739696-G-T | Benign (Dec 31, 2019) | |||
X-151739710-G-C | Benign (Dec 31, 2019) | |||
X-151739716-G-A | not specified | Likely benign (Dec 20, 2022) | ||
X-151739729-C-T | not specified | Uncertain significance (Jun 11, 2024) | ||
X-151740821-C-T | Benign (Dec 31, 2019) | |||
X-151740867-C-A | not specified | Uncertain significance (Aug 08, 2023) | ||
X-151742616-C-T | Likely benign (Dec 31, 2019) | |||
X-151742636-C-T | not specified | Uncertain significance (May 26, 2024) | ||
X-151742637-G-A | not specified | Conflicting classifications of pathogenicity (Oct 07, 2024) | ||
X-151743137-C-T | Uncertain significance (Sep 21, 2015) | |||
X-151743138-G-A | Benign (Jul 10, 2018) | |||
X-151743206-T-C | not specified | Uncertain significance (Feb 17, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CNGA2 | protein_coding | protein_coding | ENST00000329903 | 6 | 6854 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000982 | 0.988 | 125720 | 8 | 12 | 125740 | 0.0000795 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0285 | 273 | 272 | 1.00 | 0.0000219 | 4365 |
Missense in Polyphen | 111 | 118.43 | 0.9373 | 1953 | ||
Synonymous | -0.294 | 109 | 105 | 1.04 | 0.00000806 | 1308 |
Loss of Function | 2.24 | 8 | 18.3 | 0.436 | 0.00000158 | 277 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000731 | 0.0000731 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000722 | 0.0000544 |
Finnish | 0.0000626 | 0.0000462 |
European (Non-Finnish) | 0.000172 | 0.000123 |
Middle Eastern | 0.0000722 | 0.0000544 |
South Asian | 0.000105 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Odorant signal transduction is probably mediated by a G- protein coupled cascade using cAMP as second messenger. The olfactory channel can be shown to be activated by cyclic nucleotides which leads to a depolarization of olfactory sensory neurons.;
- Pathway
- cAMP signaling pathway - Homo sapiens (human);Olfactory transduction - Homo sapiens (human);NO-cGMP-PKG mediated Neuroprotection;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane;Cilium Assembly;Organelle biogenesis and maintenance
(Consensus)
Recessive Scores
- pRec
- 0.114
Intolerance Scores
- loftool
- 0.0646
- rvis_EVS
- 0.49
- rvis_percentile_EVS
- 79.61
Haploinsufficiency Scores
- pHI
- 0.290
- hipred
- Y
- hipred_score
- 0.546
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.132
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cnga2
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); craniofacial phenotype; growth/size/body region phenotype; taste/olfaction phenotype;
Gene ontology
- Biological process
- sensory perception of smell;response to stimulus;cation transmembrane transport
- Cellular component
- Golgi membrane;integral component of membrane;Golgi-associated vesicle membrane;ciliary membrane
- Molecular function
- intracellular cAMP-activated cation channel activity;intracellular cGMP-activated cation channel activity;calmodulin binding;cAMP binding;cGMP binding